Influence of pyridoxylidene aminoguanidine on biomarkers of the oxidative stress and selected metabolic parameters of rats with diabetes mellitus

General Physiology and Biophysics

Volumn 28, Issue 4, 2009, Pages 347-355

  Országhová, Zuzana ^a   Liptáková, Anna ^a   Muchová, Jana ^a   Uličná, Ol'ga ^a   Vančová, Ol'ga ^a   Sivoňová, Monika ^b   Božek, Peter ^c   Čársky, Jozef ^a   Ďuračková, Zdeňka ^a  

^a Bratislava   (Slovakia)

^b University Hospital in Martin   (Slovakia)

^c State Hospital   (Slovakia)

Author keywords

Diabetes mellitus; Free radicals; Oxidative stress; Pyridoxylidene aminoguanidine

Indexed keywords

ALKADIENE; AMINOGUANIDINE; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; DNA; INSULIN; LIPOPROTEIN; PYRIDOXYLIDENE AMINOGUANIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONJUGATION; CONTROLLED STUDY; DNA DAMAGE; DRUG ACTIVITY; DRUG STRUCTURE; LIPID OXIDATION; MALE; METABOLIC PARAMETERS; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; STRUCTURE ACTIVITY RELATION;

ALDEHYDES; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; DIABETES MELLITUS; DNA DAMAGE; GUANIDINES; LIPOPROTEINS; MALE; MALONDIALDEHYDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PYRIDOXAL; RATS; RATS, WISTAR; SOLUBILITY; WATER;

ANIMALIA; RATTUS;

EID: 77349123997     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2009_04_347     Document Type: Article

References (58)

1. Aliciguzel Y., Ozen I., Aslan M., Karayalcin U. (2003): Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J. Lab. Clin. Med. 142, 172-177; doi:10.1016/S0022-2143(03)00110-0
2. Andican G., Burcak G. (2005): Oxidative damage to nuclear DNA in streptozotocin-diabetic rat liver. Clin. Exp. Pharmacol. Physiol. 32, 663-666; doi:10.1111/j.0305-1870.2005.04247.x
3. Aruoma O. I. (1998): Free radicals, oxidants and antioxidants: trend towards the year 2000 and beyond. In: Molecular Biology of Free Radicals in Human Diseases. (Eds. O. I. Aruoma and B. Halliwell), pp. 1-28, OICA International, Saint Lucia, London
4. Baynes J. W., Thorpe S. R. (1999): Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48, 1-9; doi:10.2337/diabetes.48.1.1
5. Brown R. K., Kelly F. J. (1996): Peroxides and other products. In: Free Radicals. A Practical Approach. (Eds. N. A. Punchard and F. J. Kelly), pp. 119-131, Oxford University Press, Oxford
6. Castelao J. E., Gago-Dominguez M. (2008): Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med. Hypotheses 71, 39-44; doi:10.1016/j.mehy.2007.10.016
7. Cerielo A. (2006): Oxidative stress and diabetes-associated complications. Endocr. Pract. Suppl. 1, 60-62
8. Chen A. S., Taguchi T., Aoyama S., Sugiura M., Hurana M., Wang M. W., Miwa I. (2003) Antioxidant activity of a Schiff base of pyridoxal and aminoguanidine. Free Radic. Biol. Med. 35, 1392-1403; doi:10.1016/j.freeradbiomed.2003.08.014
9. Collins A. R., Dobson V. L., Dušinská M., Kennedy G., Štetina R. (1997): The comet assay: What can it really tell us? Mutat. Res. 375, 183-193; doi:10.1016/S0027-5107(97)00013-4
10. Coughlan M. T., Thallas-Bonke V., Pete J., Long D. M., Gasser A., Tong D. C., Arnstein M., Thorpe S. R., Cooper M. E., Forbes J. M. (2007): Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology 148, 886-895; doi:10.1210/en.2006-1300
11. Davi G., Falco A., Patrono C. (2005): Lipid peroxidation in diabetes mellitus. Antioxid. Redox Signal 7, 256-268; doi:10.1089/ars.2005.7.256
12. Ďuračková Z (1998): Free Radicals and Antioxidants in Medicine (I). Slovak Academic Press, Bratislava (in Slovak)
13. Elangovan V., Shohami E., Gati I., Kohen R. (2000): Increased hepatic lipid soluble antioxidant capacity as compared to other organs of streptozotocin-induced diabetic rats: a cyclic voltametry study. Free Radic. Res. 32, 125-134; doi:10.1080/10715760000300131
14. El-Atat F. A., Stas S. N., McFarlane S. I., Sowers J. R. (2004): The relationship between hyperinsulinemia, hypertension and progressive renal disease. J. Am. Soc. Nephrol. 15, 2816-2827; doi:10.1097/01.ASN. 0000133698.80390.37
15. Flückinger R., Winterhalter K. H. (1976): In vitro synthesis of hemoglobin A1C. FEBS Lett. 71, 356-360; doi:10.1016/0014-5793(76)80969-6
16. Giardino I., Fard A. K., Hatchell D. L., Brownlee M. (1998): Amino-guanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47, 1114-1120; doi:10.2337/diabetes.47.7.1114
17. Gül M., Emre S., Eşrefoǧlu M., Vard N. (2008): Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats. Cornea 27, 795-801; doi:10.1097/ICO.0b013e318169d67c
18. Halliwell B., Gutteridge J. M. C. (1999): Free Radicals in Biology and Medicine. Oxford University Press, Oxford
19. Hinokio Y., Suzuki S., Hirai M., Chiba M., Hirai A., Toyota T. (1999): Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42, 995-998; doi:10.1007/s001250051258
20. Holeček V., Racek J. (1995): Importance of free radicals and advanced glycosylation end products (AGE) in diabetes mellitus. Klin. Biochem. Metab. 3, 18-22 (in Czech)
21. Ihara Y., Toyokuni S., Uchida K., Odaka H., Tanaka T., Ikeda H., Hiai H., Seino Y., Yamada Y. (1999): Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48, 927-932; doi:10.2337/diabetes.48.4.927
22. Jay D., Hitomi H., Griedling K. K. (2006): Oxidative stress and diabetic cardiovascular complications. Free Radic. Biol. Med. 40, 183-192; doi:10.1016/j.freeradbiomed.2005.06.018
23. Jenkins A. J., Thorpe S. R., Alderson N. L., Hermayer K. L., Lyons T. J., King L. P., Chassereau C. N., Klein R. L. (2004): In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes. Metabolism 53, 969-976; doi:10.1016/j.metabol.2004.01.002
24. Johnson R. N., Metcalf P. A., Baker J. R. (1982): Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin. Chim. Acta 127, 87-95; doi:10.1016/0009-8981(83)90078-5
25. Kalousová M., Zima T., Tesař V., Dusilová- Sulková S., Škrha J. (2005): Advanced glycoxidation end product in chronic diseases - clinical chemistry and genetic background. Mutat. Res. 579, 37-46; doi:10.1016/j.mrfmmm.2005.03.024
26. Kinter M. (1996): Quantitative analysis of 4-hydroxy-2-nonenal. In: Free Radicals. A Practical Approach. (Eds. N. A. Punchard and F. J. Kelly), pp. 119-131, Oxford University Press, Oxford
27. Korytár P., Sivoňová M., Maruniaková A., Uličná O., Kvasnička P., Liptáková A., Božek P., Čársky J., Ďuračková Z. (2003): Influence of 2,5-dihydroxybenzylidene aminoguanidine on lipid oxidative damage and on antioxidant levels in model diabetes mellitus. Pharmazie 58, 733-734
28. Leinonen J., Lehtimaki T., Toyokuni S., Okada K., Tanaka T., Hiai H., Ochi H., Laippala P., Rantalaiho V., Wirta O., Pasternack A., Alho H. (1997): New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 417, 150-152; doi:10.1016/S0014-5793(97)01273-8
29. Liptáková A (1999): Atherosclerosis and free radicals. In: Free Radicals and Antioxidants in Medicine (II). (Eds. Z. Ďurač ková, L. Bergendi and J. Čársky), pp. 135-176, Slovak Academic Press, Bratislava (in Slovak)
30. Liptáková A., Čársky J., Uličná O., Vančová O., Božek P., Ďuračková Z. (2002): Influence of β-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus. Physiol. Res. 51, 277-284
31. Lyons T. J., Jenkins A. J. (1997): Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Metab. Rev. 5, 365-391
32. Machado A. P., Pinto R. S., Moyses Z. P., Nakandakare E. R., Quintao E. C., Passarelli M. (2006): Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. Int. J. Biochem. Cell Biol. 38, 392-403; doi:10.1016/j.biocel.2005.09.016
33. Miyazaki Y., Kawano H., Yoshida T., Miyamoto S., Hokamaki J., Nagayoshi Y., Yamabe H., Nakamura H., Yodoi J., Ogawa H. (2007): Pancreatic B-cell function is altered by oxidative stress induced by acute hyperglycaemia. Diabet. Med. 24, 154-160; doi:10.1111/j.1464-5491.2007.02058.x
34. Monnier V. M., Sell D. R., Dai Z., Nemet I., Collard F., Zhang J. (2008): The role of the Amadori product in the complications of diabetes. Ann. N. Y. Acad. Sci. 1126, 81-88; doi:10.1196/annals.1433.052
35. Muchová J. (1999): Diabetes mellitus and antioxidants. In: Free Radicals and Antioxidants in Medicine (II). (Eds. Z. Ďurač ková, L. Bergendi and J. Čársky), pp. 203-232, Slovak Academic Press, Bratislava (in Slovak)
36. Muellenbach E. A., Diehl C. J., Teachey M. K., Lindborg K. A., Archuleta T. L., Harrell N. B., Andersen G., Somoza V., Hasselwander O., Matuschek M., Henriksen E. J. (2008): Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat. Metabolism 57, 1465-1472; doi:10.1016/j.metabol.2008.05.018
37. Niedowicz D. M., Daleke D. L. (2005): The role of oxidative stress in diabetic complications. Cell Biochem. Biophys. 43, 289-330; doi:10.1385/CBB:43:2:289
38. Ou P., Wolff S. P. (1993): Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol. 46, 1139-1144; doi:10.1016/0006-2952(93)90461- 5
39. Park K. S., Kim J. H., Kim M. S., Kim J. M., Kim S. K., Choi J. Y., Chung M. H., Han B., Kim S. Y., Lee H. K. (2001): Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes 50, 2837-2841; doi:10.2337/diabetes.50.12.2837
40. Popov I. N., Lewin G. (1994): Photochemiluminescent detection of antiradical activity: II. Testing of nonenzymic water-soluble antioxidants. Free Radic. Biol. Med. 17, 267-271; doi:10.1016/0891-5849(94)90082-5
41. Robertson R. P., Harmon J. S. (2006): Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet β cell. Free Radic. Biol. Med. 41, 177-184; doi:10.1016/j.freeradbiomed. 2005.04.030
42. Schnitzer E., Pinchuk I., Bor A., Fainaru M., Samuni A. M., Lichtenberg D. (1998): Lipid oxidation in unfractionated serum and plasma. Chem. Phys. Lipids 92, 151-171; doi:10.1016/S0009-3084(98)00021-8
43. Shahab A. (2006): Why does diabetes mellitus increase the risk of cardiovascular disease? Acta Med. Indones. 38, 33-41
44. Shin C. S., Moon B. S., Park K. S., Kim S. J., Park S. J., Chung M. H., Lee H. K. (2001): Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 24, 733-737; doi:10.2337/diacare.24.4.733
45. Simmons R. A. (2006): Developmental origins of diabetes: the role of oxidative stress. Free Radic. Biol. Med. 40, 917-922; doi:10.1016/j.freeradbiomed.2005.12.018
46. Skamarauskas J. T., McKay A. G., Hunt J. V. (1996): Aminoguanidine and its pro-oxidant effects on an experimental model of protein glycation. Free Radic. Biol. Med. 21, 801-812; doi:10.1016/0891-5849(96)00183-9
47. Stoppa G. R., Cesquini M., Roman E. A., Ogo S. H., Torsoni M. A. (2006): Aminoguanidine prevent impairment of blood antioxidant system in insulin-dependent diabetic rats. Life Sci. 78, 1352-1361; doi:10.1016/j.lfs.2005.07.031
48. Suziki S., Hinokio Y., Komatu K., Ohtomo M., Onoda M., Hirai S., Hirai M., Hirai A., Chiba M., Kasuga S., Akai H., Toyota T. (1999): Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res. Clin. Pract. 45, 161-168; doi:10.1016/S0168-8227(99)00046-7
49. Tanimoto M., Gohda T., Kaneko S., Hagiwara S., Murakoshi M., Aoki T., Yamada K., Ito T., Matsumoto M., Horikoshi S., Tomino Y. (2007): Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. Metabolism 56, 160-167; doi:10.1016/j.metabol.2006.08.026
50. Thomas M. C., Baynes J. W., Thorpe S. R., Cooper M. E. (2005): The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Targets 6, 453-474; doi:10.2174/1389450054021873
51. Traverso N., Menini S., Odeti P., Pronzato M. A., Cottalasso D., Marinari M. (2002): Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic. Biol. Med. 32, 350-359; doi:10.1016/S0891-5849(01) 00811-5
52. Tsukahara H. (2007): Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr. Med. Chem. 14, 339-351; doi:10.2174/092986707779941177
53. Vasan S., Foiles P., Founds H. (2003): Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. Arch. Biochem. Biophys. 419, 89-96; doi:10.1016/j.abb.2003.08.016
54. Vasavada N., Agarwal R. (2005): Role of oxidative stress in diabetic nephropathy. Adv. Chronic Kidney Dis. 12, 146-154; doi:10.1053/j.ackd. 2005.01.001
55. Vojtaššák J., Čársky J., Danišovič L., Böhmer D., Blaško M., Braxatorisová T. (2006): Effect of pyridoxylidene aminoguanidine on human diploid cells B-HEF-2: in vitro cytotoxicity test and cytogenetic analysis. Toxicol. in Vitro 20, 868-873; doi:10.1016/j.tiv.2005.12.009
56. Wolff S. P. (1996): Free radicals and glycation theory. In: The Maillard Reaction: Consequence for the Chemical and Life Sciences. (Ed. R. Ikan), pp. 77-88, John Wiley Sons Ltd.
57. Wu L. L., Chiou C. C., Chang P. Y, Wu J. T. (2004): Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin. Chim. Acta 339, 1-9; doi:10.1016/j.cccn.2003.09.010
58. Wu M. S., Liang J. T., Lin Y. D., Wu E. T., Tseng Y. Z., Chang K. C. (2008): Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes. Br. J. Pharmacol. 154, 758-764; doi:10.1038/bjp.2008.119